Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Chong Kun Dang Pharmaceutical
Chong Kun Dang Pharmaceutical
Regor Pharmaceuticals Inc.
Cogent Biosciences, Inc.
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
WestVac Biopharma Co., Ltd.
M.D. Anderson Cancer Center
Emory University
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Shanghai Gynecologic Oncology Group
Anhui Provincial Hospital
AstraZeneca
Medigene AG
Aromics Therapeutics
Danatlas Pharmaceuticals Co., Ltd
Anhui Provincial Hospital
Zhejiang University
Corregene Biotechnology Co., Ltd